Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 USD | -3.00% | -7.78% | -21.10% |
Financials (USD)
Sales 2024 * | 133M | Sales 2025 * | - | Capitalization | 163M |
---|---|---|---|---|---|
Net income 2024 * | -64M | Net income 2025 * | -188M | EV / Sales 2024 * | 1.73 x |
Net Debt 2024 * | 67.55M | Net Debt 2025 * | 127M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.56
x | P/E ratio 2025 * |
-0.95
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on Gossamer Bio, Inc.
1 day | -3.00% | ||
1 week | -7.78% | ||
Current month | +1.41% | ||
1 month | -19.57% | ||
3 months | -23.97% | ||
6 months | +14.34% | ||
Current year | -21.10% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.72 | -3.00% | 1,362,935 |
24-05-10 | 0.7423 | -0.44% | 1,049,955 |
24-05-09 | 0.7456 | -1.30% | 1,682,721 |
24-05-08 | 0.7554 | +3.27% | 4,245,939 |
24-05-07 | 0.7315 | -6.30% | 2,115,496 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.10% | 163M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.78% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- GOSS Stock